Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of "At-home" Titration of Solifenacin 5 and 10mg and Effect on Symptoms and Quality of Life in a Typical OAB Population

NCT00759577 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00759577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00759577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of "At-home" Titration of Solifenacin 5 and 10mg and Effect on Symptoms and Quality of Life in a Typical OAB Population
Lead sponsor
NYU Langone Health
Phase
Phase 4
Overall status
Terminated
Start date
September 30, 2008
Completion date
May 31, 2010
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder